Welcome to Glycotope, the worldwide leading biopharmaceutical company in glycomics and its application for development of biopharmaceuticals.
Our unique expertise in optimizing the glycosylation of biopharmaceuticals enables us to deliver better therapeutic products.
For information about our GMP manufacturing capabilities and CE-certified immunodiagnostic kits please visit Glycotope Biotechnology
Glycooptimization of biotherapeu- tics (based on a toolbox of human glycoengineered cell lines) & recombinant antibody technologies
Proprietary and largely improved second generation antibodies & other biotherapeutics
Development of biotherapeutics from the gene via glycoopti- mization to the drug produced under cGMP including Fill & Finish
  Immunodiagnostic Kits |
 GMP-Production |
Geneva, Switzerland
Sep. 29-30, 2010
Paris, France
Oct. 5-7, 2010
Berlin, Germany
Oct 27-28, 2010
